Filana Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $95.5M | $128.6M | $121.1M | $201.0M | $233.4M | $93.5M | $23.1M | $19.8M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $97.7M | $136.5M | $129.6M | $211.2M | $244.5M | $94.0M | $23.3M | $20.0M |
| Property, Plant & Equipment | $20.6M | $21.0M | $21.9M | $22.9M | $20.6M | $11.0K | $47.0K | $87.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $193.0K | $37.0K | $176.0K | $622.0K | $1.1M | — | — | — |
| Total Assets | $118.4M | $157.5M | $151.7M | $234.8M | $266.8M | $94.3M | $23.5M | $20.1M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | $4.0M | $7.1M | $911.0K | $453.0K | $294.0K |
| Total Current Liabilities | $43.8M | $11.8M | $14.2M | $7.1M | $12.5M | $1.9M | $1.4M | $511.0K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $44.0M | $11.8M | $14.2M | $7.3M | $12.9M | $2.1M | $1.4M | $511.0K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-496.1M | $-405.1M | $-380.8M | $-283.6M | $-207.3M | $-174.9M | $-168.6M | $-164.0M |
| Total Stockholders' Equity | $74.4M | $145.7M | $137.5M | $227.5M | $253.9M | $92.2M | $22.1M | $19.6M |